Pages that link to "Q37911948"

The following pages link to Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. (Q37911948):

Displaying 47 items.

• Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes (Q28271456) (← links)
• Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination. (Q31098318) (← links)
• How to facilitate early diagnosis of CNS involvement in malignant lymphoma (Q31133442) (← links)
• Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response (Q33409443) (← links)
• A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial (Q33416656) (← links)
• Low-dose whole brain radiotherapy with tumor bed boost after methotrexate-based chemotherapy for primary central nervous system lymphoma (Q34043390) (← links)
• Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma (Q34050020) (← links)
• Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system (Q34072931) (← links)
• Clinicopathologic analysis of localized nasal/paranasal diffuse large B-cell lymphoma (Q34612336) (← links)
• EBV-associated lymphomas in adults (Q34636601) (← links)
• Second malignancies in patients with primary central nervous system lymphoma (Q35788720) (← links)
• Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement (Q37155119) (← links)
• Pathogenesis and management of primary CNS lymphoma (Q38010799) (← links)
• HIV-associated opportunistic infections of the CNS. (Q38019772) (← links)
• Diagnosis and treatment of primary CNS lymphoma (Q38106613) (← links)
• Primary lymphoma of the central nervous system--a diagnostic challenge (Q38129351) (← links)
• CNS lymphoma: a practical diagnostic approach (Q38210047) (← links)
• Present and future treatment options for primary CNS lymphoma (Q38587122) (← links)
• Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. (Q38626297) (← links)
• Advances in Pathobiology of Primary Central Nervous System Lymphoma (Q38641508) (← links)
• Primary intraventricular central nervous system lymphoma in an immunocompetent patient (Q38672812) (← links)
• Expression of Tim-1 in primary CNS lymphoma (Q38742256) (← links)
• The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma. (Q38784265) (← links)
• Primary central nervous system lymphoma: essential points in diagnosis and management (Q39185721) (← links)
• 5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma. (Q39192460) (← links)
• Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center. (Q39241718) (← links)
• Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study (Q39484584) (← links)
• Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma (Q40704991) (← links)
• The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma. (Q40831533) (← links)
• Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma (Q41593361) (← links)
• Epstein-Barr virus frequency in primary central nervous system lymphomas in Turkey (Q43805594) (← links)
• Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma. (Q47143045) (← links)
• Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding (Q47151942) (← links)
• Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. (Q48133464) (← links)
• [Primary vitreoretinal lymphoma]. (Q52626341) (← links)
• Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study. (Q52887343) (← links)
• The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing. (Q53022781) (← links)
• The Diagnosis and Treatment of Primary CNS Lymphoma (Q56967801) (← links)
• Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS (Q57301962) (← links)
• Primary Central Nervous System Lymphoma (Q59621722) (← links)
• Comparative study on different therapies on patients with primary central nervous system lymphoma (Q64112873) (← links)
• MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma (Q84449890) (← links)
• Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system (Q85952940) (← links)
• [Lenalidomide, rituximab and dexamethasone for the treatment of recurrent/refractory or elderly newly diagnosed patients with primary central nervous system lymphoma: 5 cases report and literature review] (Q89550272) (← links)
• Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma (Q90480744) (← links)
• APRIL and BAFF: novel biomarkers for central nervous system lymphoma (Q90727923) (← links)
• Prognostic significance of immunohistochemical subtypes based on the stage of B-cell differentiation in primary CNS lymphoma (Q92617944) (← links)